Sangeeta Ray Banerjee

6PUBLICATIONS
4CO-AUTHORS
Toxicology (incl. clinical toxicology)Molecular targetsPharmaceutical delivery technologiesGene and molecular therapyPolymerisation mechanisms
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2022
Correction to: Hetero-bivalent agents targeting FAP and PSMA.

Srikanth Boinapally, Alla Lisok, Gabriela Lofland

|Aug 14, 2022
Hetero-bivalent agents targeting FAP and PSMA.

Srikanth Boinapally, Alla Lisok, Gabriela Lofland

|Aug 11, 2019
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Sangeeta Ray Banerjee, Vivek Kumar, Ala Lisok

|Apr 20, 2019
Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer.

Wojciech G Lesniak, Srikanth Boinapally, Sangeeta Ray Banerjee

|Mar 27, 2019
MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.

Ethel J Ngen, Babak Benham Azad, Srikanth Boinapally

|Mar 07, 2018
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.

Sangeeta Ray Banerjee, Xiaolei Song, Xing Yang

Pageof 1

Frequent Collaborators

5 joint publications

Martin G Pomper

1 joint publications

Michael T McMahon

1 joint publications

Wojciech G Lesniak

1 joint publications

Sridhar Nimmagadda